240 related articles for article (PubMed ID: 20189489)
1. Vaccination targeting surface FomA of Fusobacterium nucleatum against bacterial co-aggregation: Implication for treatment of periodontal infection and halitosis.
Liu PF; Shi W; Zhu W; Smith JW; Hsieh SL; Gallo RL; Huang CM
Vaccine; 2010 Apr; 28(19):3496-505. PubMed ID: 20189489
[TBL] [Abstract][Full Text] [Related]
2. Halitosis vaccines targeting FomA, a biofilm-bridging protein of fusobacteria nucleatum.
Liu PF; Huang IF; Shu CW; Huang CM
Curr Mol Med; 2013 Sep; 13(8):1358-67. PubMed ID: 23865430
[TBL] [Abstract][Full Text] [Related]
3. The protective effect of recombinant FomA-expressing Lactobacillus acidophilus against periodontal infection.
Ma L; Ding Q; Feng X; Li F
Inflammation; 2013 Oct; 36(5):1160-70. PubMed ID: 23644821
[TBL] [Abstract][Full Text] [Related]
4. A novel vaccine targeting Fusobacterium nucleatum against abscesses and halitosis.
Liu PF; Haake SK; Gallo RL; Huang CM
Vaccine; 2009 Mar; 27(10):1589-95. PubMed ID: 19162109
[TBL] [Abstract][Full Text] [Related]
5. Biochemical characterization of a recombinant Lactobacillus acidophilus strain expressing exogenous FomA protein.
Ma L; Li F; Zhang X; Feng X
Arch Oral Biol; 2018 Aug; 92():25-31. PubMed ID: 29747062
[TBL] [Abstract][Full Text] [Related]
6. [Acquisition and the immunogenicity of the outer membrane FomA protein of
Ma L; Feng XP; Wu QL; Zhang XY; Zhang X
Zhonghua Kou Qiang Yi Xue Za Zhi; 2018 Oct; 53(10):674-680. PubMed ID: 30392224
[No Abstract] [Full Text] [Related]
7. NOX1/2 activation in human gingival fibroblasts by Fusobacterium nucleatum facilitates attachment of Porphyromonas gingivalis.
Ahn SH; Song JE; Kim S; Cho SH; Lim YK; Kook JK; Kook MS; Lee TH
Arch Microbiol; 2016 Aug; 198(6):573-83. PubMed ID: 27071620
[TBL] [Abstract][Full Text] [Related]
8. Porphyromonas gingivalis outer membrane vesicles inhibit the invasion of Fusobacterium nucleatum into oral epithelial cells by downregulating FadA and FomA.
Zhang Z; Liu S; Zhang S; Li Y; Shi X; Liu D; Pan Y
J Periodontol; 2022 Apr; 93(4):515-525. PubMed ID: 34458990
[TBL] [Abstract][Full Text] [Related]
9. Label-free quantitative proteomic analysis of the oral bacteria Fusobacterium nucleatum and Porphyromonas gingivalis to identify protein features relevant in biofilm formation.
Ali Mohammed MM; Pettersen VK; Nerland AH; Wiker HG; Bakken V
Anaerobe; 2021 Dec; 72():102449. PubMed ID: 34543761
[TBL] [Abstract][Full Text] [Related]
10. Fusobacterium nucleatum envelope protein FomA is immunogenic and binds to the salivary statherin-derived peptide.
Nakagaki H; Sekine S; Terao Y; Toe M; Tanaka M; Ito HO; Kawabata S; Shizukuishi S; Fujihashi K; Kataoka K
Infect Immun; 2010 Mar; 78(3):1185-92. PubMed ID: 20008529
[TBL] [Abstract][Full Text] [Related]
11. Cetylpyridinium chloride suppresses gene expression associated with halitosis.
Liu J; Ling JQ; Wu CD
Arch Oral Biol; 2013 Nov; 58(11):1686-91. PubMed ID: 24112735
[TBL] [Abstract][Full Text] [Related]
12. Immunological Pathways Triggered by
de Andrade KQ; Almeida-da-Silva CLC; Coutinho-Silva R
Mediators Inflamm; 2019; 2019():7241312. PubMed ID: 31341421
[No Abstract] [Full Text] [Related]
13. [A preliminary study on the effect of histatin 5 inhibiting
Wang HY; Liu JW; Li Q; Tan LS; Lin L; Pan YP
Zhonghua Kou Qiang Yi Xue Za Zhi; 2018 Mar; 53(3):150-156. PubMed ID: 29972970
[No Abstract] [Full Text] [Related]
14. Quantitative proteomic analysis of extracellular matrix extracted from mono- and dual-species biofilms of Fusobacterium nucleatum and Porphyromonas gingivalis.
Mohammed MMA; Pettersen VK; Nerland AH; Wiker HG; Bakken V
Anaerobe; 2017 Apr; 44():133-142. PubMed ID: 28285095
[TBL] [Abstract][Full Text] [Related]
15. Localization of the Fusobacterium nucleatum T18 adhesin activity mediating coaggregation with Porphyromonas gingivalis T22.
Kinder SA; Holt SC
J Bacteriol; 1993 Feb; 175(3):840-50. PubMed ID: 8380804
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of malodorous gas formation by oral bacteria with cetylpyridinium and zinc chloride.
Kang JH; Kim DJ; Choi BK; Park JW
Arch Oral Biol; 2017 Dec; 84():133-138. PubMed ID: 28987726
[TBL] [Abstract][Full Text] [Related]
17. Prior exposure of mice to Fusobacterium nucleatum modulates host response to Porphyromonas gingivalis.
Choi J; Borrello MA; Smith E; Cutler CW; Sojar H; Zauderer M
Oral Microbiol Immunol; 2001 Dec; 16(6):338-44. PubMed ID: 11737656
[TBL] [Abstract][Full Text] [Related]
18. Effect of Fusobacterium nucleatum on the T and B cell responses to Porphyromonas gingivalis in a mouse model.
Gemmell E; Bird PS; Carter CL; Drysdale KE; Seymour GJ
Clin Exp Immunol; 2002 May; 128(2):238-44. PubMed ID: 11985513
[TBL] [Abstract][Full Text] [Related]
19. Cloning of the fomA gene, encoding the major outer membrane porin of Fusobacterium nucleatum ATCC10953.
Jensen HB; Skeidsvoll J; Fjellbirkeland A; Høgh B; Puntervoll P; Kleivdal H; Tommassen J
Microb Pathog; 1996 Nov; 21(5):331-42. PubMed ID: 8938641
[TBL] [Abstract][Full Text] [Related]
20. Enhanced attachment of Porphyromonas gingivalis to human fibroblasts mediated by Fusobacterium nucleatum.
Metzger Z; Blasbalg J; Dotan M; Weiss EI
J Endod; 2009 Jan; 35(1):82-5. PubMed ID: 19084131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
